This information is disseminated under the sponsorship of the U.S. Department of Transportation
in the interest of information exchange.
The United States Government assumes no Liability for the contents or use thereof.
Selegiline |
| Description |
ELDEPRYLŪ is a treatment for parkinson disease. It's primary metabolite is L-methamphetamine. |
| Therapeutic Low |
0.0010 |
| Therapeutic High |
0.0200 |
| Units |
ug/mL |
| Specimen |
P |
| Half Life Low |
0.80 |
| Half Life High |
0.02 |
| VOD Low |
0.80 |
| VOD High |
2.20 |
| Toxic Level |
14.000 |
| Lethal Level |
38.000 |
| Plasma to Whole Blood ratio |
0.00 |
| Warnings |
|